Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.

× No keyword cloud information.

8 in total

Review 1. Changing concepts: Menopausal hormone therapy and breast cancer.

Authors: Rowan T Chlebowski; Garnet L Anderson
Journal: J Natl Cancer Inst Date: 2012-03-16 Impact factor: 13.506

2. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.

Authors: Diego Munoz; Aimee M Near; Nicolien T van Ravesteyn; Sandra J Lee; Clyde B Schechter; Oguzhan Alagoz; Donald A Berry; Elizabeth S Burnside; Yaojen Chang; Gary Chisholm; Harry J de Koning; Mehmet Ali Ergun; Eveline A M Heijnsdijk; Hui Huang; Natasha K Stout; Brian L Sprague; Amy Trentham-Dietz; Jeanne S Mandelblatt; Sylvia K Plevritis
Journal: J Natl Cancer Inst Date: 2014-09-24 Impact factor: 13.506

Review 3. Menopausal hormone therapy and breast cancer mortality: clinical implications.

Authors: Rowan T Chlebowski; Garnet L Anderson
Journal: Ther Adv Drug Saf Date: 2015-04

4. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.

Authors: Rowan T Chlebowski; JoAnn E Manson; Garnet L Anderson; Jane A Cauley; Aaron K Aragaki; Marcia L Stefanick; Dorothy S Lane; Karen C Johnson; Jean Wactawski-Wende; Chu Chen; Lihong Qi; Shagufta Yasmeen; Polly A Newcomb; Ross L Prentice
Journal: J Natl Cancer Inst Date: 2013-03-29 Impact factor: 13.506

5. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.

Authors: Andrea Z LaCroix; Rowan T Chlebowski; JoAnn E Manson; Aaron K Aragaki; Karen C Johnson; Lisa Martin; Karen L Margolis; Marcia L Stefanick; Robert Brzyski; J David Curb; Barbara V Howard; Cora E Lewis; Jean Wactawski-Wende
Journal: JAMA Date: 2011-04-06 Impact factor: 56.272

The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.

Review 1. Changing concepts: Menopausal hormone therapy and breast cancer.

2. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.

Review 3. Menopausal hormone therapy and breast cancer mortality: clinical implications.

4. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.

5. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.

Review 6. Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.

7. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.

8. Risk Models for Breast Cancer and Their Validation.